Perspectives on the Treatment of Multiple Myeloma
The treatment of multiple myeloma has evolved significantly over the past few decades with
the development of novel therapeutics. The introduction of proteasome inhibitors …
the development of novel therapeutics. The introduction of proteasome inhibitors …
Current status of drug repositioning in hematology
A Ohmoto, S Fuji - Expert Review of Hematology, 2021 - Taylor & Francis
Introduction Drug repositioning (DR) is defined as determining new therapeutic applications
for existing drugs. This approach is advantageous over de novo drug discovery in …
for existing drugs. This approach is advantageous over de novo drug discovery in …
[HTML][HTML] Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma
A Azvolinsky - 2024 - ashpublications.org
The combination of daratumumab plus lenalidomide (DR) resulted in more patients with
newly diagnosed multiple myeloma (NDMM) converting from measurable residual disease …
newly diagnosed multiple myeloma (NDMM) converting from measurable residual disease …